# Study of Amantadine for Weight Stabilization During Olanzapine Treatment

> **NCT00287352** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 40 (actual)

## Conditions studied

- Psychotic Disorder
- Schizophreniform Disorder
- Schizophrenia
- Schizoaffective Disorder
- Mood Disorders With Psychotic Features

## Interventions

- **DRUG:** Olanzapine, Amantadine
- **DRUG:** Olanzapine and placebo

## Key facts

- **NCT ID:** NCT00287352
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2011-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287352, "Study of Amantadine for Weight Stabilization During Olanzapine Treatment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00287352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*